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eveloping sympathetic neurons die by apoptosis
when deprived of NGF. BIM, a BH3-only member
of the BCL-2 family, is induced after NGF withdrawal
in these cells and contributes to NGF withdrawal–induced
death. Here, we have investigated the involvement of the
Forkhead box, class O (FOXO) subfamily of Forkhead tran-
scription factors in the regulation of BIM expression by
NGF. We ﬁnd that overexpression of FOXO transcription
D
 
factors induces BIM expression and promotes death of
sympathetic neurons in a BIM-dependent manner. In addi-
tion, we ﬁnd that FKHRL1 (FOXO3a) directly activates the
 
bim
 
 promoter via two conserved FOXO binding sites and
that mutation of these sites abolishes 
 
bim
 
 promoter activation
after NGF withdrawal. Finally, we show that FOXO activity
contributes to the NGF deprivation–induced death of sym-
pathetic neurons.
 
Introduction
 
Programmed cell death (PCD) accounts for the death of
 
approximately half of all neurons generated during embryo-
genesis and is essential for the correct innervation of target
tissues and formation of neuronal networks during neural
development (Oppenheim, 1991; Yuan and Yankner, 2000).
A well-studied model of neuronal PCD is provided by sym-
pathetic neurons, which depend on NGF for survival during
early postnatal life. Developing sympathetic neurons undergo
apoptosis when deprived of NGF in culture, providing a useful
in vitro system for studying the molecular mechanisms of
neuronal PCD (Deshmukh and Johnson, 1997).
NGF deprivation activates the intrinsic pathway of apoptosis
in sympathetic neurons (Putcha et al., 2002). This involves
the release of cytochrome 
 
c
 
 from the mitochondria into the
cytosol which is regulated by members of the BCL-2 family
through their ability to influence mitochondrial integrity
(Hengartner, 2000). NGF withdrawal–induced apoptosis of
sympathetic neurons can be blocked by inhibitors of RNA
and protein synthesis (Martin et al., 1988), suggesting that
increased expression of specific genes is necessary for this
death, and it has been shown that expression of the proapop-
totic BH3–only BCL-2 family members DP5/HRK and
BIM increases after NGF withdrawal (Imaizumi et al., 1997;
Putcha et al., 2001; Whitfield et al., 2001). Overexpression
of each protein can induce cytochrome 
 
c
 
 release, and apoptosis
in the presence of NGF and BIM is required for normal
NGF withdrawal–induced death (a complementary require-
ment for DP5 has not yet been reported). In addition, the c-Jun
NH
 
2
 
-terminal kinase (JNK)–c-Jun pathway has been shown
to contribute to the up-regulation of both BIM and DP5 after
NGF withdrawal (Harris and Johnson, 2001; Whitfield et
al., 2001). Coordinate up-regulation of the 
 
bim
 
 and 
 
dp5/hrk
 
genes, therefore, provides a link between activation of the
JNK–c-Jun pathway, which is a critical early consequence of
NGF deprivation, and cytochrome 
 
c
 
 release (Estus et al., 1994;
Ham et al., 1995; Eilers et al., 1998; Whitfield et al., 2001).
Although the JNK–c-Jun pathway appears to play a signif-
icant role in BIM induction after NGF withdrawal in sym-
pathetic neurons, its precise contribution is still unclear and
the involvement of other signaling pathways cannot be ruled
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out. Therefore, it is of note that JNK–c-Jun activation con-
tributes to BIM induction in cerebellar granule neurons de-
prived of serum and depolarizing potassium, but the ability
of insulin-like growth factor-1 to block this induction is not
a result of JNK–c-Jun inhibition (Linseman et al., 2002).
Instead, the insulin-like growth factor-1–mediated regula-
tion of BIM expression correlates with the phosphorylation
status of FKHRL1 (FOXO3a), a Forkhead transcription fac-
tor of the Forkhead box, class O (FOXO) subfamily, which
has previously been implicated in the induction of BIM ex-
pression in hematopoietic cells deprived of their trophic sup-
port (Dijkers et al., 2000, 2002; Stahl et al., 2002).
The FOXO transcription factors, FKHR (FOXO1),
FKHRL1 (FOXO3a), and AFX (FOXO4), share DNA-
binding specificity to a core consensus site (Furuyama et
al., 2000) and are targets of phosphatidylinositol 3-kinase
(PI3-K) signaling, which regulates their activity via phos-
phorylation mediated by protein kinase B/Akt and serum and
glucocorticoid–induced kinase (SGK; Burgering and Kops,
2002). In pro-B and T cells, trophic factor deprivation and
inhibition of PI3-K activity cause FKHRL1 dephosphoryla-
tion, induction of BIM expression, and FKHRL1-depen-
dent apoptosis (Dijkers et al., 2000, 2002; Stahl et al.,
2002). In addition, overexpression of constitutively active
FKHRL1 can induce BIM expression and apoptosis in the
presence of survival signaling in these cells (Dijkers et al.,
2000; Stahl et al., 2002). In neurons, the contribution of
FOXO transcription factors to BIM induction and apopto-
sis is less clear. Constitutively active FKHRL1 can induce
apoptosis in cerebellar granule neurons, but this appears to
be Fas dependent (Brunet et al., 1999). Furthermore, al-
though BIM induction in cerebellar granule neurons corre-
lates with dephosphorylation of FKHRL1 (Linseman et al.,
2002), a direct requirement for FOXO transcription factors
has not been demonstrated.
Here, we have investigated the role of FOXO transcrip-
tion factors in NGF-dependent sympathetic neurons. We
report that FOXO transcription factors can directly activate
the 
 
bim
 
 promoter and that this contributes to the induction
of 
 
bim
 
 gene expression after NGF withdrawal. In addition,
we find that FOXO activity is required for normal NGF
withdrawal–induced apoptosis in these cells.
 
Results
 
The 
 
bim
 
 gene is regulated by the PI3-K pathway in 
sympathetic neurons
 
To determine whether the PI3-K pathway regulates BIM ex-
pression in sympathetic neurons, we used the pharmacologi-
Figure 1. PI3-K signaling regulates bim gene expression in 
sympathetic neurons. (A) PI3-K inhibition by LY294002 induces 
BIM protein levels. Neurons cultured with ( ) or without ( ) NGF, 
were treated with 50  M LY294002 ( LY) or vehicle (DMSO) for 16 h 
and BIM expression assessed by immunoblotting. A representative blot 
is shown. Changes in BIM protein levels were determined by 
densitometry after normalization to tubulin to control for loading. 
Values represent  SEM of three experiments. (B) PI3-K inhibition 
induces bim mRNA levels. Neurons were treated as in A and bim 
and neurofilament-M (NF-M) mRNA levels were assessed by RT-PCR. 
Representative gel images are shown. Changes in bim mRNA levels 
were determined as changes in band intensity on ethidium bromide–
stained 2.5% agarose gels after normalization to NF-M to control for 
sample input. Values represent  SEM of five experiments.
Figure 2. NGF regulates the phosphorylation and localization 
of FKHRL1 in sympathetic neurons. (A) NGF regulates FKHRL1 
phosphorylation via PI3-K. Neurons were cultured with or without 
NGF ( NGF), or treated with 100  M LY294002 ( LY) for 16 h. 
FKHRL1 expression and phosphorylation was then assessed by 
immunoblotting using anti-FKHRL1 and antiphospho (Thr
32)-FKHRL1 
antibodies. Representative blots are shown (asterisk indicates the 
phospho-specific antibody detects a nonspecific band of this size). 
(B) NGF regulates FKHRL1 localization. Neurons were injected with 
an expression construct encoding 0.1 mg/ml wild-type FKHRL1 
together with guinea pig (gp) IgG as a marker and were cultured 
with or without NGF ( NGF) for 16 h. Neurons were then fixed 
and stained with Hoechst dye to visualize nuclei, and antibodies 
to gp IgG and the HA epitope to identify injected cells and detect 
HA-tagged FKHRL1. Representative images are shown. FKHRL1 
localization was classified as cytoplasmic when nuclei showed no 
significant signal with anti-HA staining, and nuclear when the signal 
was greater in the nucleus than cytoplasm. In many neurons the 
staining pattern was ambiguous. Percentages representing  SEM of 
three experiments are shown. Bar, 10  m.T
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FOXO transcription factors can induce BIM 
expression and promote a BIM-dependent 
death of sympathetic neurons
 
To investigate whether FOXO transcription factors can
regulate 
 
bim
 
 gene expression in sympathetic neurons, we in-
fected the cells with an adenovirus expressing a constitu-
tively active murine FKHR mutant, FKHR(ADA) (Nakae et
al., 2001). We found that FKHR(ADA), which localized to
the nucleus as expected (not depicted), consistently induced
BIM protein and 
 
bim
 
 mRNA levels compared with neurons
infected with a control LacZ adenovirus (Fig. 3 A).
Because FKHR(ADA) was found to induce expression of
the proapoptotic BIM protein, we next investigated whether
expression of a constitutively active FOXO transcription fac-
tor, in this case FKHRL1(A3), could induce sympathetic
neurons to die in the presence of NGF, and whether this was
dependent upon BIM expression. In this analysis, we used a
 
bim
 
 antisense strategy to inhibit BIM expression (Whitfield
et al., 2001). We found that the 
 
bim
 
 antisense oligonucle-
otides greatly reduced BIM protein levels in transfected
PC12 cells, compared with the corresponding missense oli-
gonucleotides, whereas levels of other BCL-2 family mem-
bers (both pro- and antiapoptotic) and procaspase-3 were
relatively unaffected (Fig. 3 B). The effect of FKHRL1(A3)
expression on neuronal survival could, therefore, be evalu-
ated in the context of normal or inhibited BIM expression.
Neurons were injected with an FKHRL1(A3) expression
construct or empty vector, together with a mixture of the
 
bim
 
 antisense oligonucleotides or the corresponding scram-
bled missense oligonucleotides, and their survival was
tracked over a 3-d period (Fig. 3 C). When coinjected with
the missense oligonucleotides, we observed significantly
increased death of neurons expressing FKHRL1(A3) com-
pared with the corresponding control neurons. Further-
more, this depended on BIM expression because coinjec-
 
cal inhibitor LY294002 to inhibit PI3-K activity. In immu-
noblotting experiments, we observed a sixfold increase in
BIM
 
EL
 
 protein levels in sympathetic neurons treated with 50
 
 
 
M LY294002 to a level that is 
 
 
 
30% of the induction
(21-fold) seen after NGF deprivation (Fig. 1 A). In addition,
using reverse transcription PCR (RT-PCR), we found that
the same treatment resulted in a more robust induction of
 
bim
 
 mRNA to a level that is 
 
 
 
60% of that seen for NGF
withdrawal (Fig. 1 B).
 
NGF regulates FKHRL1 phosphorylation 
and localization in sympathetic neurons
 
Several trophic factors, including NGF in PC12 cells
(Zheng et al., 2002), regulate the activity of FOXO tran-
scription factors via PI3-K signaling and Akt/SGK-medi-
ated phosphorylation at three critical regulatory sites (Bur-
gering and Kops, 2002). This promotes nuclear export of
these factors and blocks their ability to transactivate their
target genes. In immunoblotting experiments, we found
that FKHRL1 is expressed in sympathetic neurons and that
phosphorylation at one of the critical phosphorylation sites
(Thr
 
32
 
) substantially decreases after NGF withdrawal (Fig.
2 A). Furthermore, this phosphorylation requires PI3-K ac-
tivity because it was inhibited by LY294002 (Fig. 2 A). We
also found that NGF withdrawal promoted the transloca-
tion of ectopically expressed HA-tagged human FKHRL1
from the cytoplasm to the nucleus (Fig. 2 B), whereas a
constitutively active human FKHRL1 mutant, FKHRL1(A3),
containing mutations in its regulatory phosphorylation sites
(Brunet et al., 1999), localized to the nucleus even in the
presence of NGF (not depicted). Therefore, NGF with-
drawal promotes changes in FKHRL1 phosphorylation and
localization in sympathetic neurons that would be consis-
tent with a role in the transcriptional up-regulation of the
 
bim
 
 gene.
Figure 3. FOXO transcription factors 
induce bim gene expression and promote 
a BIM-dependent death of sympathetic 
neurons. (A) FKHR(ADA) expression 
increases endogenous BIM protein and 
bim mRNA levels. Neurons were infected 
with a control adenovirus (LacZ) encoding 
 -galactosidase ( -Gal) or an adenovirus 
encoding FKHR(ADA). BIM, FKHR, 
and  -Gal expression was assessed by 
immunoblotting (IB), and bim mRNA 
levels were assessed by RT-PCR. Tubulin 
and NF-M are loading and sample input 
controls. Images are representative of 
at least three experiments. (B) BIM 
expression can be selectively inhibited 
by bim antisense oligonucleotides. Naïve 
PC12 cells were cotransfected with bim 
antisense (AS) or missense (MS) oligonucleotides and an expression construct encoding GFP, and were sorted for GFP expression by FACS
® 
after 24 h. BIM, BAX, BCL-2, BCL-XL, and procaspase-3 protein levels in GFP-positive cells were then assessed by immunoblotting. Tubulin 
represents a loading control. Blots are representative of three experiments. (C) Neurons were injected with 0.2 mg/ml of an FKHRL1(A3) 
expression construct or empty vector together with 0.03 mg/ml of bim antisense (AS) or missense (MS) oligonucleotide mixtures, and Texas 
red dextran as a marker. Cells were left to recover for 4–6 h (time 0) and survival of the injected neurons were determined as the percentage 
of viable cells at each time point relative to time 0. Values represent   SEM of four experiments. FKHRL1(A3) expression significantly increased 
death of neurons injected with missense oligonucleotides (P   0.05, t tests, FKHRL1(A3)   MS vs. vector   MS), and this was blocked in 
neurons injected with the bim antisense oligonucleotides (FKHRL1(A3)   AS). The antisense oligonucleotides had no significant independent 
effect upon neuronal survival (vector   AS).T
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tion of the 
 
bim
 
 antisense oligonucleotides prevented the
FKHRL1(A3)-induced death.
 
NGF withdrawal, PI3-K inhibition, and FKHRL1 
activate the 
 
bim
 
 promoter
 
To further investigate the mechanisms involved in regula-
tion of the 
 
bim
 
 gene in sympathetic neurons, we cloned the
5
 
 
 
 end of the rat 
 
bim
 
 gene (including a 2.5-kb region up-
stream of the major transcription start site, the noncoding
exon 1, the 2.4-kb first intron, and the noncoding region of
exon 2) upstream of the Firefly luciferase coding region to
generate a 
 
bim
 
-LUC reporter (Fig. 4 A), which has promoter
activity in transiently transfected neuronal PC12 cells (not
depicted). The effect of NGF withdrawal on 
 
bim
 
 promoter
activity was assessed by luciferase immunostaining in cul-
tured sympathetic neurons injected with the 
 
bim
 
-LUC re-
porter (Fig. 4 B), which provided us with an indicator of re-
porter activity in individual injected cells. We observed a
significant increase in the percentage of injected neurons ex-
pressing luciferase after NGF withdrawal. In addition, re-
porter activation after NGF withdrawal was confirmed by
assaying for luciferase activity in injected neurons (Fig. 4 C).
These data indicate that the 
 
bim
 
 promoter is activated after
NGF withdrawal in sympathetic neurons.
Next, we tested whether inhibition of PI3-K activity by
LY294002 or overexpression of FOXO transcription factors
could also activate the 
 
bim
 
 promoter in sympathetic neurons
in the presence of NGF. We found that 
 
bim
 
-LUC reporter
activity (as assessed by luciferase immunostaining) increased
significantly in injected neurons treated with LY294002 (Fig.
4 D) and increased in a dose-dependent manner in neurons
expressing constitutively active FKHRL1(A3) and, to a lesser
extent, wild-type FKHRL1 (Fig. 4 E). Although FKHRL1(A3)
was found to be a potent activator at both high and low con-
centrations, wild-type FKHRL1 did not significantly activate
the reporter at the lower concentration, and only caused a
modest activation, relative to FKHRL1(A3), at the higher
concentration. This is consistent with the ability of NGF to
regulate the localization of wild-type FKHRL1, but not
FKHRL1(A3) (Fig. 2 and text), with some FKHRL1 escap-
ing regulation by NGF when expressed at high levels.
These results indicated that the 
 
bim
 
-LUC reporter be-
haves in a similar manner to the endogenous 
 
bim
 
 gene with
respect to regulation by NGF, the PI3-K pathway, and
FOXO transcription factors. The 
 
bim
 
-LUC reporter could,
therefore, be used to further investigate the involvement of
FOXO transcription factors in 
 
bim
 
 promoter activation after
NGF withdrawal.
Figure 4. The bim promoter is activated by NGF 
withdrawal, PI3-K inhibition, and FKHRL1(A3) 
expression in sympathetic neurons. (A) Structure 
of the 5  end of the rat bim gene and the bim-LUC 
reporter. Exons are shown as boxes; clear regions 
represent 5  untranslated region and shaded 
regions coding sequence. An arrow indicates the 
major transcription start site ( 1), as determined 
by 5  RACE. The bim-LUC reporter consists of the 
5.2-kb region 5  to the bim initiator codon in 
pGL3-Basic. (B) Luciferase immunostaining reveals 
that the bim promoter is activated after NGF with-
drawal in neurons injected with the bim-LUC 
reporter. Neurons were injected with 0.01 mg/ml 
of the bim-LUC reporter and gp IgG as a marker 
and were cultured with or without NGF ( NGF) 
for 20–24 h. Cells were then fixed and stained with 
Hoechst dye to visualize nuclei, and antibodies to 
gp IgG and luciferase to identify injected cells and 
to assess luciferase expression. Typical images 
are shown. Bar, 10  m. Neurons were scored as 
expressing luciferase when staining was significantly 
greater than background staining in uninjected 
neurons. The data represent  SEM of six experiments 
(*, P   0.05, t test,  NGF vs.  NGF). Bar, 10  m. 
(C) Assaying for luciferase activity confirms bim 
promoter activation after NGF withdrawal. Neurons 
were injected with 0.01 mg/ml of the bim-LUC 
reporter and 0.005 mg/ml of the Renilla luciferase 
expression construct pRL-TK, to control for injection, 
and were cultured with or without NGF ( NGF) 
for 18–20 h after which luciferase assays were 
performed. The relative fold change in Firefly activity was determined after normalization to Renilla activity. The data represent  SEM of four 
experiments. (*, P   0.002, t test,  NGF vs.  NGF). (D) The bim promoter is activated by LY294002. Neurons injected as in B were treated 
with 50  M LY294002 or DMSO ( ) for 20–24 h in the presence of NGF and the percentage of injected cells expressing luciferase determined 
as in (B). The data represent  SEM of five experiments (*, P   0.001, t test, LY294002 vs. DMSO). (E) The bim promoter is activated by FKHRL1(A3). 
Neurons were injected with 0.01 mg/ml of the bim-LUC reporter, gp IgG, and either 0.01 or 0.1 mg/ml of wild-type (wt) FKHRL1 or FKHRL1(A3) 
expression construct or equimolar amounts of empty vector ( ) and were maintained in the presence of NGF. After 20–24 h, the percentage 
of injected cells expressing luciferase was determined as in B. The data represent  SEM of at least three experiments (*, P   0.02 and **, P   0.005, 
t tests, FKHRL1(A3) vs. vector).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 FOXO transcription factors regulate bim in neurons | Gilley et al. 617
FOXO binding sites are located at the 5  end 
of the bim gene
A search of the 5  end of the bim gene identified four poten-
tial FOXO binding sites that closely match a consensus
GTAAACAA described previously (Furuyama et al., 2000),
two of which—one at position  204 relative to the tran-
scription start site (bim1) and one at the boundary between
exon 1 and the first intron (bim2; Fig. 5 A)—are conserved
between rodents and humans. The ability of FKHRL1 to
bind to these sites was, therefore, tested in an electrophoretic
mobility shift assay using a purified fusion protein (GST-
FKH) consisting of the DNA-binding domain (DBD) of
FKHRL1(A3) fused to GST. As expected, GST-FKH
bound to a control oligonucleotide (Fas ligand [FasL]) con-
taining a known FOXO site from the FasL promoter (Bru-
net et al., 1999), whereas an unrelated GST fusion protein
(GST-c-Jun) did not (Fig. 5 A; and Fig. 5 B, lanes 2 and 6).
GST-FKH also bound to oligonucleotides containing the
bim1 and bim2 sites but did not bind to mutated versions
(mut1 and mut2) of these sites (Fig. 5 A; and Fig. 5 B, lanes
7–14). A 500-fold molar excess of unlabeled FasL oligonu-
cleotide prevented formation of the GST-FKH–FasL com-
plex and complex formation was also significantly reduced
by unlabeled bim1 and bim2 oligonucleotides (Fig. 5 B,
lanes 3–5). The FasL oligonucleotide competed more effec-
tively than the bim1 and bim2 oligonucleotides perhaps be-
cause it contains two overlapping FOXO sites (Fig. 5 A).
These data indicate that the bim1 and bim2 sites are FOXO
binding sites.
FOXO binding sites are required for activation of the 
bim promoter by FKHRL1 and NGF withdrawal
Next, we investigated whether the bim1 and bim2 FOXO
binding sites are necessary for activation of the bim pro-
moter by FKHRL1(A3) and by NGF withdrawal using bim-
LUC reporter constructs with mutations in these sites. The
mutations that prevented GST-FKH binding to these sites
(Fig. 5) were introduced into the reporter by site-directed
mutagenesis to generate the single mutants, bim-LUC(m1)
and bim-LUC(m2), and a double mutant, bim-LUC(dm)
(Fig. 6 A).
The mutant bim-LUC reporters were initially tested for
their ability to be activated by FKHRL1(A3). Neuronal
PC12 cells were transiently cotransfected with the bim-LUC
reporters and an FKHRL1(A3) expression construct or
empty vector and luciferase activity determined 24 h later
(Fig. 6 B). Activation of the bim-LUC reporter by
FKHRL1(A3) was found to be dose dependent and the sin-
gle FOXO site mutations in the bim-LUC(m1) and bim-
LUC(m2) reporters only slightly diminished this activation.
In contrast, activation of the bim-LUC(dm) reporter was
greatly reduced compared with the wild-type reporter and
this was especially apparent at the lower concentration of
FKHRL1(A3). Modest activation of the bim-LUC(dm) re-
porter at the higher concentration of FKHRL1(A3) con-
struct may be mediated by the two nonconserved FOXO
binding sites more distal to the bim promoter. These results
indicate that bim promoter activation by FKHRL1(A3) can
be mediated by either the bim1 or the bim2 FOXO sites and
that mutation of both is necessary to substantially reduce
this activation.
Next, we tested whether the bim1 and bim2 FOXO sites
are also required for activation of the bim promoter after
NGF withdrawal in sympathetic neurons. Neurons were in-
jected with the bim-LUC and bim-LUC(dm) reporters and
their ability to be activated by NGF withdrawal was deter-
mined by luciferase immunostaining (Fig. 6 C). Whereas
the wild-type bim-LUC reporter was activated as before,
there was no apparent activation of the bim-LUC(dm) dou-
ble mutant reporter because no significant increase in the
number of injected neurons expressing luciferase was ob-
served after NGF withdrawal. The ability of NGF with-
drawal to activate the reporters was additionally investigated
Figure 5. FKHRL1 binds to FOXO binding sites located close to 
the bim promoter. (A) The consensus binding site for the FOXO 
subfamily of Forkhead transcription factors and a known FOXO 
binding site in the Fas ligand promoter (FasL) are compared with the 
conserved bim1 and bim2 sites located close to the bim promoter. 
Deviation from the consensus at positions 1, 6, and 8 is not 
uncommon. Overlapping FasL FOXO sites are underlined. Mutated 
versions of the bim1 and bim2 sites (mut1 and mut2) are also shown 
(mutations are boxed). The bim2 site spans the bim exon 1/intron 1 
splice site so the mut2 mutations were designed to minimize the 
chance of disrupting splicing (mut2 fits the GTRAGT donor splice 
consensus). (B) Purified GST-FKH protein was tested for binding to 
double-stranded 
32P-labeled oligonucleotides containing the FasL 
site and the wild-type and mutant bim sites listed in A by electro-
phoretic mobility shift assay. A representative gel is shown. An arrow 
indicates the mobility of specific complexes between GST-FKH and 
the labeled oligonucleotides. GST-c-Jun was incubated with the FasL 
oligonucleotide (lane 6) as a negative control. GST-FKH binding to 
the FasL oligonucleotide was competed with a 500-fold excess (500 ) 
of unlabeled FasL, bim1, or bim2 oligonucleotide (lanes 3–5).T
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at the mRNA level by RT-PCR (Fig. 6 D). Activation of the
wild-type bim-LUC reporter was again observed, this time as
an increase in normalized bim-LUC mRNA levels after NGF
withdrawal, but there was no apparent activation of the bim-
LUC(dm) reporter. Therefore, the bim1 and bim2 FOXO
binding sites appear to be required for bim promoter activa-
tion after NGF withdrawal in sympathetic neurons, at least
in the context of the bim-LUC reporter.
FOXO activity contributes to NGF 
withdrawal–induced death
Because BIM expression contributes to NGF withdrawal–
induced death (Putcha et al., 2001; Whitfield et al., 2001)
and the FKHRL1(A3)-induced death of sympathetic neu-
rons (Fig. 3 C), we investigated whether FOXO transcrip-
tional activity contributes to NGF withdrawal–induced
death. To inhibit FOXO activity, we generated an ex-
pression construct encoding FKH(DBD)—the DBD of
FKHRL1(A3) with a FLAG epitope tag (Fig. 7 A). This re-
gion of FKHRL1 can bind to FOXO sites in DNA (Fig. 5)
and can act as a competitive inhibitor of FKHRL1-medi-
ated transcription (Dijkers et al., 2002). We found that
FKH(DBD) localizes to the nucleus in sympathetic neurons
(Fig. 7 B) and is a specific inhibitor of FOXO transcrip-
tional activity: FKH(DBD) could inhibit FKHRL1(A3)-
mediated activation of the bim-LUC reporter but did not
block activation of the c-jun-LUC reporter by MEK kinase 1
(MEKK1), which involves activation of the JNK–c-Jun
pathway and is not dependent on FOXO activity (Fig. 7 C).
Next, we investigated the effect of FKH(DBD) expression
on the survival of sympathetic neurons for 3 d after NGF
withdrawal (Fig. 7 D). Survival of neurons injected with the
FKH(DBD) expression construct was compared directly to
neurons injected with either empty vector or an expression
construct encoding FLAG 169, a dominant negative c-Jun
mutant, which delays NGF withdrawal–induced death as ef-
fectively as Bcl-2 (Ham et al., 1995). A significantly higher
percentage of survival was seen at all time points for cells ex-
pressing FKH(DBD) compared with those injected with
empty vector, and FKH(DBD) expression protected cells
from death as effectively as FLAG 169. This indicates that
FOXO activity contributes significantly to the NGF depri-
vation–induced death of sympathetic neurons.
Discussion
We have found that FOXO transcription factors regulate
transcription of the bim gene in sympathetic neurons. The
Figure 6. FOXO binding sites are required for 
bim promoter activation by FKHRL1(A3) and NGF 
withdrawal. (A) Structure of bim-LUC reporters 
containing mutations in the bim1 and bim2 FOXO 
sites. Reporters are represented as in Fig. 4 A. Wild-
type sites are represented by shaded circles and 
mutated sites by crosses. The location of primers 
used for RT-PCR (D) is also shown. (B) Mutation of 
the bim1 and bim2 sites substantially reduces bim 
promoter activation by FKHRL1(A3). Neuronal 
PC12 cells were transiently transfected with 
the indicated reporters together with varying 
concentrations of the FKHRL1(A3) expression 
construct pECE-FKHRL1(A3) or empty vector and 
the Renilla luciferase expression construct pRL-TK 
to control for transfection efficiency. Luciferase 
activity was determined after 24 h and Firefly 
activity was normalized to Renilla activity. The 
fold change in normalized Firefly luciferase activ-
ity of cells transfected with pECE-FKHRL1(A3) rela-
tive to empty vector is plotted. The data represent 
 SEM of at least three experiments. pGL3-Pro-
moter (pGL3-P), an SV40-LUC reporter, is in-
cluded for reference. Activation of bim-LUC(dm) 
was significantly reduced at both concentrations 
compared to bim-LUC (P   0.02 at 0.33  g and 
P   0.002 at 1  g, t tests). (C) The bim1 and bim2 
mutations abolish bim promoter activation after 
NGF withdrawal. Sympathetic neurons were 
injected with 0.01 mg/ml of the bim-LUC or bim-
LUC(dm) reporters together with gp IgG and were 
cultured with ( ) or without ( ) NGF for 20–22 h. 
Reporter activities were then determined by luciferase immunostaining as in Fig. 4 B. The data represent the mean of six experiments   SEM 
(*, P   0.002, t test, bim-LUC  NGF vs.  NGF). (D) Sympathetic neurons were injected with 0.02 mg/ml of the bim-LUC or bim-LUC(dm) 
reporters together with 0.01 mg/ml of pRL-TK to act as an injection control. Cells were then cultured with ( ) or without ( ) NGF for 16 h 
and bim-LUC and Renilla luciferase (Renilla) mRNA levels were determined by RT-PCR. A bim-specific and luciferase-specific primer spanning 
bim intron 1 (A) were used for bim-LUC amplification to prevent amplification from endogenous bim transcripts and to confirm that mutation 
of the bim2 site did not affect splicing. Relative changes in bim-LUC levels after NGF withdrawal were then calculated as changes in band 
intensities on ethidium-stained 2.5% agarose gels after normalization to Renilla levels. The data represent the mean of three experiments   
SEM (*, P   0.025, t test, wild-type bim-LUC mRNA levels  NGF vs.  NGF). Representative gel images are also shown.T
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observations that FKHRL1 is expressed in sympathetic neu-
rons and that its PI3-K–dependent phosphorylation and lo-
calization are regulated by NGF in these cells is consistent
with this (Fig. 2). In addition, our finding that expression of
constitutively active FKHRL1 can activate the bim promoter
in these cells (Fig. 4), and that this is largely abolished when
two conserved FOXO binding sites located close to the bim
promoter are mutated to prevent FOXO binding (Figs. 5
and 6), demonstrate that the bim gene is a direct FOXO tar-
get. This had previously only been implied based on a corre-
lation between BIM expression levels and FKHRL1 phos-
phorylation status (Dijkers et al., 2000; Linseman et al.,
2002; Stahl et al., 2002). More importantly, these FOXO
binding sites appear to be required for bim promoter activa-
tion after NGF withdrawal in sympathetic neurons. Al-
though these results were obtained using synthetic bim-LUC
reporter constructs, we have found that the wild-type re-
porter behaves in a similar manner to the endogenous gene
when subjected to a variety of stimuli. Therefore, we can
predict that FOXO transcription factors contribute to the
up-regulation of the bim gene in sympathetic neurons de-
prived of NGF.
We have also demonstrated an important role for FOXO
transcription factors in the induction of apoptosis in sympa-
thetic neurons. As well as showing that expression of consti-
tutively active FKHRL1 can induce death (Fig. 3), we have
also found that inhibition of FOXO activity can protect
sympathetic neurons against NGF withdrawal–induced
death (Fig. 7). Most of the FKHRL1(A3)-induced death oc-
curred during the first 48 h, after which the rate of death
was comparable to that of control neurons. Although this
may simply reflect the fact that FKHRL1(A3) is expressed
transiently in these assays, it is also possible that a subpopu-
lation of the neurons are resistant to this death. Similarly,
the observation that inhibition of FOXO activity does not
block NGF withdrawal–induced death indefinitely might be
due to the transient nature of the assay, although it is also
possible that the eventual death of these neurons is the result
of the NGF withdrawal–induced activation of FOXO-inde-
pendent pathways, such as the JNK pathway.
The finding that FKHRL1(A3)-mediated death of sympa-
thetic neurons is dependent on BIM expression (Fig. 3) sug-
gests that the bim gene is a critical proapoptotic target of
FOXO transcription factors in these cells. Given that bim
deletion and BIM inhibition confer transient protection
against NGF withdrawal–induced apoptosis (Putcha et al.,
2001; Whitfield et al., 2001), inhibition of bim transcrip-
tion probably contributes to the delay in NGF withdrawal–
induced death when FOXO activity is inhibited. However,
other FOXO-regulated genes could also be involved in this
apoptosis. One possible candidate is the FasL gene which
can be activated by FKHRL1 and which is modestly in-
duced at the RNA level in NGF-deprived sympathetic neu-
rons (Putcha et al., 2002), as well as in neuronal PC12 cells
and cerebellar granule neurons deprived of survival signals
(Brunet et al., 1999; Le-Niculescu et al., 1999). However,
an analysis of sympathetic neurons with inactivating muta-
tions in their FasL or Fas genes suggested that the Fas path-
way does not contribute to NGF withdrawal–induced death
(Putcha et al., 2002). Other potential candidates include the
Figure 7. Inhibition of FOXO activity delays the 
NGF withdrawal–induced death of sympathetic 
neurons. (A) Structure of FKHRL1 and FKH(DBD). 
Key regulatory phosphorylation sites are shown for 
FKHRL1. FKH(DBD) is the DNA-binding domain 
(DBD) of FKHRL1 (amino acids 141–268) with the 
S253A mutation found in FKHRL1(A3) and an NH2-
terminal FLAG epitope tag. (B) FKH(DBD) localizes 
to the nucleus. Neurons were injected with 0.05 
mg/ml of the FKH(DBD) expression construct and 
gp IgG. After 24 h, neurons were fixed and stained 
with Hoechst dye, to visualize nuclei, and antibodies 
to gp IgG and the FLAG epitope to identify 
injected cells and detect FLAG-tagged FKH(DBD). 
Representatives images are shown. Bar, 10  m. 
(C) FKH(DBD) is a specific inhibitor of FOXO 
transcriptional activity. Neurons were injected 
with either 0.01 mg/ml of the bim-LUC reporter or 
0.001 mg/ml of the c-jun-LUC reporter together 
with expression vectors (or the corresponding empty 
vectors) for 0.01 mg/ml of FKHRL1(A3), 0.1 mg/ml 
of MEKK1, and 0.05 mg/ml of FKH(DBD) as 
indicated, and gp IgG as a marker. 20–24 h later 
the percentage of cells expressing luciferase was 
determined (as in Fig. 1). The averages of at least 
three experiments  SEM are shown. FKHRL1(A3) and MEKK1 significantly increased luciferase expression in cells injected with the bim-LUC 
and c-jun-LUC reporters respectively (*, P   0.02, **, P   0.05, t test), but FKH(DBD) only inhibited activation of the bim-LUC reporter 
by FKHRL1(A3) (
§ indicates P   0.005, t test). (D) Sympathetic neurons were injected with expression constructs encoding FKH(DBD) or 
FLAG 169 (a dominant-negative c-Jun mutant), or empty vector (all at 0.05 mg/ml) together with Texas red dextran as a marker. Cells were 
allowed to recover overnight and were then deprived of NGF. The number of viable injected neurons was determined at 0, 24, 48, and 72 h 
after NGF withdrawal. Survival is expressed as a percentage of the number of viable injected neurons at time 0. Experiments were performed 
in a blinded manner and the average of three experiments  SEM is shown. Survival was significantly increased by FKH(DBD) compared with 
empty vector (P   0.005 at 24 h, P   0.02 at 48 h, P   0.01 at 72 h, t tests).T
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genes encoding transforming growth factor- 2, the BH3-
only protein NIP3, and the cysteine protease legumain,
which have all been identified as FOXO targets (Samatar et
al., 2002; Tran et al., 2002). One way to test whether other
FOXO-regulated genes might contribute to this death
would be to assess whether inhibition of FOXO activity
confers additional protection against NGF withdrawal–
induced death in bim deficient neurons.
Use of the pharmacological inhibitor LY294002 in this
work enabled us to assess the role of the PI3-K signaling
pathway in the regulation of the bim gene. However, in addi-
tion to its ability to inhibit FOXO activity, PI3-K signaling
can also inhibit the JNK pathway in some cell types via Akt-
mediated phosphorylation of mixed lineage kinase 3 (Barth-
wal et al., 2003). Therefore, the demonstration that c-Jun
phosphorylation increases in sympathetic neurons treated
with LY294002 (Tsui-Pierchala et al., 2000; Putcha et al.,
2001) suggests that cross-talk between these pathways also
occurs in these cells. However, despite the fact that PI3-K
inhibition can result in activation of c-Jun and the FOXO
transcription factors—which both appear to be important
regulators of bim transcription in these cells—the LY294002-
induced increase in bim mRNA is still only  60% of that
observed after NGF withdrawal (Fig. 1 B). Although this
may simply reflect the fact that PI3-K inhibition may not ac-
tivate these factors to the same extent as NGF withdrawal, it
is also possible that regulation of bim gene transcription by
NGF in sympathetic neurons might involve additional sig-
naling pathways and transcription factors. Furthermore, be-
cause the LY294002-induced increase of bim mRNA levels is
not fully reflected at the protein level (induced BIM protein
levels are only  30% of that seen after NGF withdrawal;
Fig. 1 A), it is possible that NGF-regulated pathways also
modulate BIM expression posttranscriptionally.
A hypothetical model of bim gene regulation by NGF in
sympathetic neurons is outlined in Fig. 8. Based on current
knowledge, it now appears that this is significantly more
complex than the comparable situation in hematopoietic cells
where the PI3-K–mediated regulation of FOXO transcrip-
tion factors alone might be responsible for full BIM induc-
tion after growth factor withdrawal (Dijkers et al., 2000,
2002; Stahl et al., 2002). Because neurons cannot be re-
placed, additional regulatory complexity may have evolved to
prevent unnecessary apoptosis resulting from inappropriate
BIM expression (Sanchez and Yuan, 2001). Therefore, fur-
ther investigation may help elucidate the relative contribu-
tions that the JNK–c-Jun and PI3-K–FOXO signaling path-
ways make to regulation of bim gene expression and
apoptosis in NGF-dependent sympathetic neurons and other
neuronal populations, and may additionally lead to the iden-
tification of other pathways that contribute to this regulation.
Materials and methods
5  RACE and library screening
5  RACE was performed on rat brain mRNA using the Marathon™ cDNA
Amplification kit (CLONTECH Laboratories, Inc.) with the bim-specific
primer 5 -ACCTTGCGATTCTGTCTGTAGG-3 . The rat bim promoter was
isolated using the 5  RACE product as a probe to screen the rat P1 artificial
chromosome (PAC) library RPCI31 (generated by P.Y. Woon and P. de
Jong, UK Human Genome Mapping Project Resource Centre, Cambridge,
UK). Restriction fragments from PAC clones 62g18 and 215h9 were sub-
cloned and sequenced.
Plasmid constructs
The bim-LUC reporter was constructed by subcloning a 5.2-kb fragment
containing the region 5  to the bim initiator codon into pGL3-Basic
(Promega). The integrity of the construct was confirmed by sequencing.
Mutations in the bim1 and bim2 sites were incorporated into the bim-LUC
reporter using the QuikChange™ XL Site-Directed Mutagenesis kit (Strat-
agene). The bim-LUC(m1) reporter was generated using oligonucleotides
5 -CAAGTCACTAGGGTACCCACGCCGGGGTGGGC-3  and 5 -GCC-
CACCCCGGCGTGGGTACCCTAGTGACTTG-3  incorporating bim1 mu-
tations (mut1). The bim-LUC(m2) reporter was generated using oligonucle-
otides 5 -GAGAAACGCAAGGTAAGTTCTCCTCGACTCCCGG-3  and
5 -CCGGGAGTCGAGGAGAACTTACCTTGCGTTTCTC-3  incorporating bim2
mutations (mut2). The bim-LUC(dm) reporter was generated by replacing
the wild-type bim1 site from bim-LUC(m2) with the mutated bim1 site
from  bim-LUC(m1) by standard cloning procedures. Sequencing con-
firmed that mutations had been incorporated correctly. The c-jun-LUC re-
porter was generated by inserting the human c-jun promoter ( 1,600 to
 170) into pGL3-Basic. pGL3-Promoter was obtained from Promega.
pCD-FKH(DBD) encoding NH2-terminal FLAG-tagged FKH(DBD) was
generated by PCR amplification of the DBD (amino acids 141–268) of
FKHRL1(A3) using primers 5 -ACTGGATCCGCTGGGGGCTCCGGGC-
AGCCG-3  and 5 -ACTGAATTCCTAGGCTGCGCGGCCACGGCTC-3  fol-
lowed by cloning into BamHI and EcoRI-restricted pcDNA1-FLAG (Vekrel-
lis et al., 1997). pECE-FKHRL1, pECE-FKHRL1(A3), both provided by M.E.
Greenberg (Harvard Medical School, Boston, MA) pMEKK1, and pCD-
FLAG 169 have been described previously (Ham et al., 1995; Eilers et al.,
1998; Brunet et al., 1999).
Cell culture and transient transfection
Sympathetic neurons were isolated from the superior cervical ganglia
(SCG) of 1-d-old Sprague Dawley rats and cultured as described previously
(Ham et al., 1995; Eilers et al., 1998). SCG medium was supplemented
with 2.5S NGF (Cedarlane) at 50 ng/ml and fluorodeoxyuridine and uri-
dine, each at 20  M. Typically 6,400–8,000 neurons were plated on 13-
mm-diam glass coverslips coated with poly-L-lysine and laminin or 10
5
neurons were plated on 3.5-cm poly-L-lysine and laminin-coated tissue
culture dishes. Cells were used for experiments after 5–7 d in vitro. In
Figure 8. Regulation of bim gene expression by NGF in sympathetic 
neurons. FOXO transcriptional activity is inhibited by NGF via PI3-K 
signaling and Akt/SGK-mediated phosphorylation. NGF withdrawal 
and LY294002 inhibit PI3-K signaling, resulting in FOXO activation 
and subsequent activation of the bim promoter via the bim1 and 
bim2 FOXO binding sites. The JNK pathway is repressed in the 
presence of NGF. PI3-K signaling could account for some of this 
repression via Akt-mediated inhibition of MLK activity but PI3-K–
independent pathways may also be involved. NGF withdrawal and 
LY294002 activate the JNK pathway via mixed lineage kinase 3 
(MLK3), resulting in c-Jun activation. Dominant-negative c-Jun (DN 
c-Jun) can partially inhibit BIM induction after NGF withdrawal, 
which suggests that c-Jun/AP-1 may also directly regulate the bim 
promoter. Furthermore, our results do not rule out the possibility 
that other transcription factors/signaling pathways might also be 
involved in regulation of bim promoter activity or that NGF might 
regulate BIM expression post transcriptionally.T
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NGF-withdrawal experiments, neurons were rinsed twice with medium
(without NGF) and were re-fed with medium containing 100 ng/ml anti-
NGF antibody. The PI3-K inhibitor LY294002 was typically used at a con-
centration of 50  M.
The PC6-3 subline of the PC12 cell line was maintained as described
previously (Pittman et al., 1993). Cells were differentiated for 5–7 d in
RPMI 1640 medium containing 2% horse serum, 1% FCS, penicillin/strep-
tomycin and 100 ng/ml of NGF (Promega) to obtain a neuronal phenotype.
Cells were transfected using Lipofectamine 2000 (Invitrogen). Naïve PC12
cells were seeded in 6-well plates at 4   10
5 cells per well and were trans-
fected 24 h later with 4  g of bim antisense or missense oligonucleotide
mixtures together with 1  g of GFP expression construct. After 24 h, GFP
expressing cells were collected by FACS
® and processed for immunoblot-
ting. For bim-LUC reporter activity assays, neuronal PC12 cells were cul-
tured in 24-well plates at 4   10
4 cells per well and were transfected with
0.5–1.5  g of reporter and expression construct DNAs together with 50 ng
of pRL-TK (Promega). A transfection efficiency of 10–20% was achieved.
Immunoblotting
Neurons were treated as described in Results, washed in ice-cold PBS, and
lysed in sample buffer (2% SDS, 2 mM  -mercaptoethanol, 60 mM Tris,
pH 6.8, and 0.01% bromphenol blue) by incubating at 100 C for 15 min.
Proteins were separated on 8–12% SDS polyacrylamide gels and trans-
ferred to Immobilon-P membrane (Millipore) using the Mini-PROTEAN III
transfer system (Bio-Rad Laboratories). Protein detection membrane strip-
ping was performed as described previously (Whitfield et al., 2001) or fol-
lowing protocols supplied with the primary antibodies. The following pri-
mary antibodies were used: rabbit polyclonal antiphospho-FKHRL1(Thr
32;
Upstate Biotechnology); anti-FKHRL1 (Upstate Biotechnology); anti–cas-
pase-3 (Upstate Biotechnology); anti-BAX (Vekrellis et al., 1997); anti-BIM
(CHEMICON International, Inc.); sheep polyclonal anti-FKHR (Upstate
Biotechnology); mouse monoclonal BCL-2 and anti–BCL-XL (BD Transduc-
tion Labs); anti– -galactosidase (Promega); and rat monoclonal antitubulin
(Serotec). Appropriate HRP-conjugated secondary antibodies (Amersham
Biosciences and Santa Cruz Biotechnology, Inc.) were used for detection
using the ECL and ECL-plus systems (Amersham Biosciences). Relative
band intensities were determined using a GS-800 calibrated densitometer
(Bio-Rad Laboratories) and Quantity One software.
RT-PCR
Neurons were treated as described in Results and RNA was isolated using
the RNeasy kit (QIAGEN). One third of the RNA were reverse transcribed
using Superscript II reverse transcriptase (Invitrogen) as instructed. Reac-
tions were made up to 200  l with water and 10  l was used in 50- l PCR
reactions containing 200  M dNTPs, oligonucleotide primers at 0.5  M,
and 0.05 U/  l of REDTaq DNA polymerase in 1X REDTaq PCR buffer
(Sigma-Aldrich). Typically 28–36 cycles of 94 C for 30 s, 59 or 60 C for
30 s, and 72 C for 30 or 60 s were performed. PCR products were resolved
on 2.5% agarose gels and visualized by ethidium bromide staining. Images
were captured using a UVItec Gel-DOC system and bands were quantified
using ImageMaster TotalLab imaging software (Amersham Biosciences).
Reactions were analyzed over a range of cycles to confirm that the PCR
amplification dynamics were in the linear range. Experiments were per-
formed at least three times and PCR was performed twice for each cDNA
sample and the average taken. Primers used were as follows: bim,  5 -
CTACCAGATCCCCACTTTTC-3  and 5 -GCCCTCCTCGTGTAAGTCTC-3 ;
neurofilament-M ( NF-M), 5 -ACGCTGGACTCGCTGGGCAA-3  and 5 -
GCGAGCGCGCTGCGCTTGTA-3 ;  bim-LUC hybrids, 5 -AGGCACTG-
GGTCAACAGC-3  and 5 -CTTTATGTTTTTGGCGTCTTCC-3 ; and Renilla
luciferase, 5 -TGATCCAGAACAAAGGAAACGG-3  and 5 -CCTGATTTG-
CCCATACCAATAAGG-3 .
Microinjection and immunocytochemistry
Neurons were microinjected as described previously (Whitfield et al.,
2001). Experiments were performed at least three times with 200 neurons
injected per injection mix. Neurons were injected with plasmids at the
concentrations indicated.
For luciferase immunostaining, neurons were coinjected with 2.5 mg/ml
purified guinea pig IgG (Sigma-Aldrich) to act as a marker and were treated
as described in Results. After 20–24 h, neurons were fixed with 4% PFA
(20 min), rinsed in PBS, and blocked with 50% horse serum in PBS (30
min). After rinsing in PBS, neurons were incubated for 1 h with a goat anti-
luciferase polyclonal antibody (Promega) diluted 1:100 in PBS containing
10% horse serum. Neurons were again rinsed in PBS and incubated for 1 h
with FITC-conjugated anti–goat IgG and rhodamine-conjugated anti-gp
IgG antibodies (Jackson ImmunoResearch Laboratories), and diluted 1:100
in PBS containing 10% horse serum. After rinsing in PBS, nuclei were then
stained with Hoechst dye at 10  g/ml in water. After a final rinse in water,
coverslips were mounted on slides in Citifluor. Slides were examined using
a fluorescence microscope (model Axioplan 2; Carl Zeiss MicroImaging,
Inc.) and images captured using a digital camera (Photometrix Quantix)
and SmartCapture VP software. Injected neurons were scored as positive
for luciferase expression when FITC staining was clearly greater than back-
ground fluorescence in neighboring uninjected cells. Experiments were
scored in a blinded manner whenever possible.
Localization of FLAG-tagged FKH(DBD) and HA-tagged FKHRL1 and
FKHRL1(A3) was determined by immunostaining using the anti-FLAG M2
(Sigma-Aldrich) and anti-HA 12CA5 (Roche) mAbs as described previously
(Ham et al., 1995; Eilers et al., 1998).
Adenoviral infection
Sympathetic neurons were cultured for 4–5 d and were infected overnight
with the required adenoviral multiplicity of infection by re-feeding with a
minimal volume of SCG medium containing recombinant adenoviruses.
Neurons were then re-fed with virus-free SCG medium and incubated for
48 h. The FKHR(ADA) adenovirus (Ad-ADA-Foxo1; provided by D. Accili,
Columbia University, New York, NY) and the LacZ adenovirus have been
described previously (Nakae et al., 2001; Whitfield et al., 2001). We used
each adenovirus at the lowest multiplicity of infection that resulted in in-
fection of  70% of neurons as determined by immunostaining for expres-
sion of the encoded proteins.
Survival assays
In survival assays, neurons were injected with expression vectors and/or
oligonucleotides (at the indicated concentrations) together with 5 mg/ml
Texas red dextran Mr   70,000 (Molecular Probes) as a marker. After treat-
ment (as described in Results), number of viable, morphologically normal
injected neurons was determined using an inverted fluorescence micro-
scope (model Axiovert 100; Carl Zeiss MicroImaging, Inc.). Viable injected
cells were recounted at 24, 48, and 72 h. Experiments were scored in a
blinded manner whenever possible. The bim antisense and missense oligo-
nucleotides have been described previously (Whitfield et al., 2001).
Luciferase assays
Luciferase assays were performed using the Dual-Luciferase reporter assay
system (Promega) and a Turner TD-20e luminometer (Jencons Scientific
Limited). Firefly output was normalized to Renilla output to control for
transfection efficiency.
Expression and purification of GST-FKH
The FKHRL1 DBD was subcloned from pCD-FKH(DBD) into pGEX-6P-2
and transformed into Escherichia coli DH5 . Expression and purification
of GST-FKH was performed according to standard procedures (Smith and
Corcoran, 1994). After purification on glutathione Sepharose 4B (Amer-
sham Biosciences), the fusion protein was mixed with glycerol (to 15%)
and DTT (to 2 mM) and stored at  80 C in aliquots. Purity was assessed by
SDS-PAGE with Coomassie blue staining.
Electrophoretic mobility shift assay
Double stranded oligonucleotides with 5  overhangs were labeled by fill-
ing in with Klenow polymerase and  -[
32P]dCTP. The following pairs of
oligonucleotides were used (FOXO sites underlined): FasLA 5 -CTA-
GAATAAGTAAATAAATAA-3  and FasLB 5 -CTAGTTATTTATTTACT-
TATT-3 ; bim1A 5 -CTAGCTAGGGTAAACACGCCG-3  and bim1B 5 -
CTAGCGGCGTGTTTACCCTAG-3 ; and bim2A 5 -CTAGGCAAGGTAAA-
CACTCCT-3  and bim2B 5 -CTAGAGGAGTGTTTACCTTGC-3 . The mut1
and mut2 oligonucleotides were identical to bim1 and bim2 except that
they contained the point mutations shown in Fig. 4 A. 20- l binding reac-
tions contained 20 mM Hepes, pH 7.9, 50 mM KCl, 2 mM MgCl2, 0.5 mM
EDTA, 2 mM DTT, 10% glycerol, 0.5 mg/ml BSA, 2  g of poly (dI dC), and
cold competitor oligonucleotide as required. 1  l of purified GST FKH was
added and the samples were incubated at room temperature for 15 min.
Finally the samples were incubated with 0.4 ng of 
32P-labeled oligonucle-
otide for 15 min and loaded onto a 6%-nondenaturing polyacrylamide gel
containing 25 mM Tris, 192 mM glycine, 1 mM EDTA, and 5% glycerol.
After electrophoresis at 4 C, the gel was fixed, dried, and exposed in
a phosphorimager cassette (Amersham Biosciences). The screen was
scanned in a Typhoon phosphorimager (Amersham Biosciences).
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